Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccination in Health Care Workers in Kalulushi District
NCT04072211Phase 4Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Nov 2019
- Primary completion
- Aug 2020
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Center for Infectious Disease Research in Zambia. Primary endpoint: Protective Hepatitis B surface antibody levels at 8 months. Started Nov 2019; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04072211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072211.